National Commission on Scleroderma and Fibrotic Diseases Act of 2019

HB 3446 National Commission on Scleroderma and Fibrotic Diseases Act of 2019

US Congress 116th Congress

National Commission on Scleroderma and Fibrotic Diseases Act of 2019
HB-3446

About HB-3446

Temporarily establishes a National Commission on Fibrotic Diseases within the National Institutes of Health that must recommend improvements regarding fibrosis and fibrotic disease research.

  

Bill Texts

Introduced 07/02/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Spread the Word!

Gettr Embed Code

Sponsors (47)

Rep. James McGovern


Co-Sponsor

Rep. Thomas Suozzi


Co-Sponsor

Rep. Nita Lowey


Co-Sponsor

Rep. Jamie Raskin


Co-Sponsor

Rep. Yvette Clarke


Co-Sponsor

Rep. Lacy Clay


Co-Sponsor

Rep. Pramila Jayapal


Co-Sponsor

Rep. Adriano Espaillat


Co-Sponsor

Rep. Mark Pocan


Co-Sponsor

Rep. Cathy McMorris Rodgers


Co-Sponsor

Rep. Paul Tonko


Co-Sponsor

Rep. Adam Smith


Co-Sponsor

Track This Bill

Get notified when this bill is updated

Sponsors by party

     

Bill Sponsors

History

Referred To The Subcommittee On Health.

06/25/2019

Introduced In House

06/24/2019

Referred To The House Committee On Energy And Commerce.

06/24/2019

Subject(s)

Health Advisory Bodies Congressional Oversight Government Studies And Investigations Health Programs Administration And Funding Health Promotion And Preventive Care Medical Research Medical Tests And Diagnostic Methods Musculoskeletal And Skin Diseases Organ And Tissue Donation And Transplantation Research Administration And Funding Research And Development